Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for diabetes, central nervous system repair, and cartilage injury were found, and a way to create functional hair follicles from stem cells was developed.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Researchers found four genes that could help diagnose severe alopecia areata early.

ILC1 cells contribute to hair loss in alopecia areata.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Higher CRBP1 levels are linked to more severe alopecia areata.

Sleep patterns might be linked to hair loss, but more research is needed.

People with Alopecia Areata have a higher risk of heart-related health issues.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Hair loss has many causes, so treatment varies.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Certain gene variations may increase the risk and severity of alopecia areata.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

SQSTM1 gene issues may increase the risk of alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Laser hair removal is safe for people with Systemic Lupus Erythematosus.

Patients with thyroid disorders show different symptoms and antibody levels.

Antibody treatments show promise for hair loss but need more research.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Oxidative stress is linked to mild patchy alopecia areata.

Low-level laser therapy can significantly regrow hair in alopecia areata.